GlaxoSmithKline | GSK - Current Liabilities


GlaxoSmithKline reported GBP21.39B in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
AbbVie USD 43.29B 3.9B Dec/2025
Alcon AG USD 3.05B 59M Dec/2025
Almirall EUR 350.64M 52.12M Dec/2025
Amgen USD 25.49B 3.7B Dec/2025
argenx SE USD 1.04B 371.99M Jun/2025
AstraZeneca USD 30.62B 3.44B Dec/2025
Bayer EUR 32.58B 3.63B Dec/2025
Biogen USD 3.35B 59.4M Dec/2025
Bristol-Myers Squibb USD 28.14B 608M Sep/2025
Eli Lilly USD 35.23B 4.91B Dec/2025
Fresenius EUR 9.56B 1.27B Sep/2025
Fresenius Medical Care EUR 6.25B 485.68M Dec/2025
Galapagos EUR 152.86M 213.7M Dec/2025
Genmab DKK 1.43B 686M Dec/2025
Gilead Sciences USD 11.81B 485M Dec/2025
GlaxoSmithKline GBP 21.39B 57M Dec/2025
Glaxosmithkline GBP 28.82B 144.79M Dec/2025
GRIFOLS EUR 2.02B 135.85M Dec/2025
Hikma Pharmaceutical USD 1.45B 603M Dec/2025
Lonza CHF 3.57B 421M Dec/2025
Merck EUR 9.04B 405M Dec/2025
Merck USD 28.63B 2.59B Sep/2025
Novartis USD 27.28B 4.72B Dec/2025
Novo Nordisk DKK 215.66B 18.7B Dec/2025
Orion EUR 560.3M 9.8M Dec/2025
Pfizer USD 36.6B 1.13B Sep/2025
Philips EUR 7.51B 479M Dec/2025
Recordati EUR 1.04B 24.44M Sep/2025
Regeneron Pharmaceuticals USD 4.37B 56.7M Dec/2025
Roche Holding CHF 28B 421M Dec/2025
Sanofi EUR 28.35B 3.76B Dec/2025
Smith & Nephew USD 1.54B 236M Dec/2025
UCB EUR 4.4B 470M Dec/2025